Skip to main content

Table 2 Breakdown of test samples used to evaluate sensitivity and specificity of three technologies

From: Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials

Product Manufacturer Field samples Additional samples Total
Accra Bolga HO Kumasi Takoradi Counter–FEIT Authentic Stressed
Artemetheter-Lumefantrine tablets, 20/120 mg Ipcaa 0 1 0 3 1 0 0 0 5
Lumerax (Artemether + Lumefantrine tablets, 40/240 mg) Ipca 2 0 0 4 5 0 0 0 11
Coartem (Artemether + Lumefantrine tablets, 20/120 mg) Novartis 2 4 3 3 2 3 0 0 17
Coartem dispersible (Artemether + Lumefantrine tablets, 20/120 mg) Novartis 4 0 3 0 3 0 3 1 14
Winthrop (Artesunate + Amodiaquine tablets, 50/135 mg) Sanofi-Aventis 8 5 1 1 10 0 3 1 29
Winthrop (Artesunate + Amodiaquine tablets, 100/270 mg) Sanofi-Aventis 1 3 1 0 3 0 0 0 8
Total 17 13 8 11 24 3 6 2 84
  1. aIpca’s Artesunate-Amodiaquine tablets were not on the market at the time of the study